Updated COVID-19 Vaccines Providing Protection Against Omicron Variant Available at No Cost The Department of Health & Human Services (HHS), through CMS announced that people with Medicare, Medicaid, Children’s Health […]
Read moreCMS Issues Addition Guidance on Emergency Preparedness Testing The Quality, Safety & Oversight (QSO) Group at the Centers for Medicare & Medicaid Services (CMS) has issued a revised QSO -20-41-All […]
Read moreCOVID-19: New Codes for Moderna Vaccine Booster Doses On March 29, 2022, the FDA amended the Moderna COVID-19 vaccine emergency use authorization (PDF), including new packaging for vaccine boosters (blue cap). CMS […]
Read moreEligible Individuals Can Receive Second COVID-19 Booster Shot at No Cost On April 6, CMS announced it will pay for a second COVID-19 booster shot of either the Pfizer-BioNTech or […]
Read moreCOVID-19 Monoclonal Antibodies: Revised Emergency Use Authorization for EVUSHELD On February 24, the FDA revised the emergency use authorization for tixagevimab co-packaged with cilgavimab (EVUSHELD™) to change the initial dose […]
Read moreCOVID-19 Monoclonal Antibodies: FDA Authorized Bebtelovimab On February 11, the FDA authorized the emergency use (PDF) of the monoclonal antibody bebtelovimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients […]
Read moreCOVID-19: New HCPCS Code for Convalescent Plasma in Outpatient Setting On December 28, the FDA revised the emergency use authorization for COVID-19 convalescent plasma with high titers of anti-SARS-CoV-2 antibodies. It’s authorized […]
Read moreBiden-Harris Administration Will Cover Free Over-the-Counter COVID-19 Tests Through Medicare CMS Developing Initiative to Enable Access to Eight Free Over-the-Counter COVID-19 Tests for Medicare Beneficiaries in Early Spring As part […]
Read more